Medicinal importance of gallic acid and its ester derivatives: a patent review

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Mohapatra PKD, Mondal KC, Pati BR. Production of tannase through submerged fermentation of tannin-containing plant extracts by Bacillus licheniformis KBR6. Pol J. Microbiol. 55(4), 297–301 (2006).
  MedlineGoogle Scholar
• 2 Prince PSM, Priscilla H, Devika PT. Gallic acid prevents lysosomal damage in isoproterenol induced cardiotoxicity in Wistar rats. Eur. J. Pharmacol. 615(1), 139–143 (2009).
  Medline CASGoogle Scholar
• 3 Verma S, Singh A, Mishra A. Gallic acid: molecular rival of cancer. Environ. Toxicol. Phar. 35(3), 473–485 (2013).•• Summarizes anticarcinogenic effects of gallic acid and its molecular mechanism.
  Medline CASGoogle Scholar
• 4 Werner I, Bacher A, Eisenreich W. Retrobiosynthetic NMR studies with 13C-labeled glucose. Formation of gallic acid in plants and fungi. J. Biol. Chem. 272(41), 25474–25482 (1997).• Reveals biosynthetic pathway of gallic acid.
  Medline CASGoogle Scholar
• 5 Urizzi P, Monje MC, Souchard JP et al. Antioxidant activity of phenolic acid and esters present in red wine on human low-density lipoproteins. J. Chim. Phys. 96, 110–115 (1999).
  CASGoogle Scholar
• 6 Li D, Liu Z, Zhao W, Xi Y, Niu F. A straightforward method to determine the cytocidal and cytopathic effects of the functional groups of gallic acid. Process Biochem. 46(11), 2210–2214 (2011).
  CASGoogle Scholar
• 7 Brewer MS. Natural antioxidants: sources, compounds, mechanisms of action, and potential applications. Compr. Rev. Food Sci. F. 10(4), 221–247 (2011).• Describes sources, molecular mechanisms and applications of various natural antioxidants
  CASGoogle Scholar
• 8 Locatelli C, Filippin-Monteiro FB, Creczynski-Pasa TB. Alkyl esters of gallic acid as anticancer agents: a review. Eur. J. Med. Chem. 60, 233–239 (2013).•• Summarizes anticarcinogenic effects of gallic acid alkyl esters and its molecular mechanism.
  Medline CASGoogle Scholar
• 9 Saeed N, Khan MR, Shabbir M. Antioxidant activity, total phenolic and total flavonoid contents of whole plant extracts Torilis leptophylla L. BMC Complem. Alt. Med. 12(1), 221 (2012).
  Medline CASGoogle Scholar
• 10 Singleton VL. Naturally occurring food toxicants: phenolic substances of plant origin common in foods. Adv. Food Res. 27, 149–242 (1981).• Summarizes plant-based natural phenolic compounds as food toxicants.
  Medline CASGoogle Scholar
• 11 Sawa T, Nakao M, Akaike T, Ono K, Maeda H. Alkylperoxyl radical-scavenging activity of various flavonoids and other phenolic compounds: implications for the anti-tumor-promoter effect of vegetables. J. Agr. Food Chem. 47(2), 397–402 (1999).
  Medline CASGoogle Scholar
• 12 Su TR, Lin JJ, Tsai CC et al. Inhibition of melanogenesis by gallic acid: possible involvement of the I3K/Akt, MEK/ERK and Wnt/β-catenin signaling pathways in B16F10 cells. Int. J. Mol. Sci. 14, 20443–20458 (2013).
  MedlineGoogle Scholar
• 13 Vaquero MJ, Alberto MR, de Nadra MC. Antibacterial effect of phenolic compounds from different wines. Food Control 18(2), 93–101 (2007).
  Google Scholar
• 14 Gali HU, Perchellet EM, Perchellet JP. Inhibition of tumor promoter-induced ornithine decarboxylase activity by tannic acid and other polyphenols in mouse epidermis in vivo. Cancer Res. 51, 2820–2825 (1991).
  Medline CASGoogle Scholar
• 15 Gali HU, Perchellet EM, Klish DS, Johnson JM, Perchellet JP. Hydrolyzable tannins: potent inhibitors of hydroperoxide production and tumor promotion in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate in vivo. Int. J. Cancer 51, 425–432 (1992).
  Medline CASGoogle Scholar
• 16 Abbasi S, Daneshfar A, Hamdghadareh S, Farmany A. Quantification of sub-nanomolar levels of gallic acid by adsorptive stripping voltammetry. Int. J. Electrochem. Sci. 6(10), 4843–4852 (2011).
  CASGoogle Scholar
• 17 Beniwal V, Kumar A, Goel G, Chhokar V. A novel low molecular weight acido-thermophilic tannase from Enterobacter cloacae MTCC 9125. Biocatal. Agric. Biotechnol. 2(2), 132–137 (2013).
  Google Scholar
• 18 Chao J, Huo TI, Cheng HY et al. Gallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD mice. PLoS ONE 9(6), e96969 (2014).• Reveals beneficial effects of GA on nutritional hepatosteatosis.
  MedlineGoogle Scholar
• 19 Hsu CL, Yen GC. Effect of gallic acid on high fat diet-induced dyslipidaemia, hepatosteatosis and oxidative stress in rats. Br. J. Nutr. 98, 727–735 (2007).• Reports gallic acid-mediated suppression of HFD-induced dyslipidemia, hepatosteatosis and oxidative stress.
  Medline CASGoogle Scholar
• 20 Sen S, Asokkumar K, Umamaheswari M, Sivashanmugam AT, Subhadradevi V. Antiulcerogenic effect of gallic acid in rats and its effect on oxidant and antioxidant parameters in stomach tissue. Indian J. Pharm. Sci. 75(2), 149–155 (2013).
  Medline CASGoogle Scholar
• 21 Dorsch W, Bittinger M, Kaas A, Müller A, Kreher B, Wagner H. Antiasthmatic effects of Galphimia glauca, gallic acid, and related compounds prevent allergen- and platelet-activating factor-induced bronchial obstruction as well as bronchial hyperreactivity in guinea pigs. Int. Arch. Allergy Immunol. 97(1), 1–7 (1992).
  Medline CASGoogle Scholar
• 22 Porat Y, Abramowitz A, Gazit E. Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem. Biol. Drug Des. 67, 27–37 (2006).
  Medline CASGoogle Scholar
• 23 Mansouri MT, Farbood Y, Sameri MJ, Sarkaki A, Naghizadeh B, Rafeirad M. Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats. Food Chem. 138(2–3), 1028–1033 (2013).
  Medline CASGoogle Scholar
• 24 Porteous Don D: US4260597A (1981).
  Google Scholar
• 25 Mario B: WO2003033006A1 (2003).
  Google Scholar
• 26 Rosen RT: US20050170022A1 (2005).
  Google Scholar
• 27 THE PROCTER & GAMBLE COMPANY: US20070185038A1 (2007).
  Google Scholar
• 28 Oliver Y-P H, Hsiong C-H, Wang M-T, Pao L-H: US20090074708A1 (2009).
  Google Scholar
• 29 BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE: US7709031B2 (2010).
  Google Scholar
• 30 NATURA COSMETICOS S.A.: WO2011020167A1 (2011).
  Google Scholar
• 31 Liu Z, Yang P: US2011/0039796A1 (2011).
  Google Scholar
• 32 ILLUMINA, INC., Klausing K: CA2825815A1 (2012).
  Google Scholar
• 33 WUHAN INSTITUTE OF VIROLOGY, CHINESEACADEMY OF SCIENCES: CN102631384A (2012).
  Google Scholar
• 34 Rabbani E, Li X, Liu D: US20120184616A9 (2012).
  Google Scholar
• 35 PUSAN NATIONAL UNIVERSITYINDUSTRY-UNIVERSITY COOPERATION FOUNDATION: WO2012173312A (2012).
  Google Scholar
• 36 Klausing K, Smith V, Shen M-JR, Moore J, Hall K: US20120196758 A.
  Google Scholar
• 37 ESTEE LAUDER COORDINATION CENTER NV, AGINOMOTO OMNICHEM SA: US8465973B2 (2013).
  Google Scholar
• 38 BEIJING AGRICULTURAL COLLEGE: CN102389411B (2013).
  Google Scholar
• 39 Tesla Fu Ai White: CN102228479B (2013).
  Google Scholar
• 40 Chuan L, Fumin L: CN103211893A (2013).
  Google Scholar
• 41 VERICOM CO., LTD: WO 2013147409A1 (2013).
  Google Scholar
• 42 SHANGHAI HUA-CHEM TECHNOLOGY DEVELOPMENTCO., LTD: CN103006720A (2013).
  Google Scholar
• 43 3M PROPERTIES COMPANY: EP2624822A2 (2013).
  Google Scholar
• 44 I.E. R. F.C. EUROPEAN INSTITUTE FORCYSTIC FIBROSIS RESEARCH: EP2664326A1 (2013).
  Google Scholar
• 45 Hoffman La Roche: US2571326A (1951).
  Google Scholar
• 46 GEIGY CHEM CORP: US3462534A (1969).
  Google Scholar
• 47 GEIGY CHEM CORP: US3679804A (1972).
  Google Scholar
• 48 GEIGY CHEM CORP: US3639622A (1972).
  Google Scholar
• 49 BAYER AKTIENGESELLSCHAFT: US4034104A (1977).
  Google Scholar
• 50 NIPPON STEEL CORPORATION: US5227358A (1993).
  Google Scholar
• 51 Masakazu A, JAPAN IMMUNO RES LAB, Masatoshi N, Hiroshi O, Izumi T, Masamichi U: WO1998043990A1 (1998).
  Google Scholar
• 52 SCHERING AKTIENGESELLSCHAFT: US6156341A (2000).
  Google Scholar
• 53 AVMAX GROUP INC, Benet LZ, Wacher VJ: WO2000051643A (2000).
  Google Scholar
• 54 KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY: US6133311A (2000).
  Google Scholar
• 55 STAGO DIAGNOSTICA, Roisin J-P, Steurs S, Quentin G: WO2002076921A1 (2000).
  Google Scholar
• 56 KIMBERLY-CLARK WORLDWIDE, INC.: US20060217443A1 (2006).
  Google Scholar
• 57 SOCIETE DIAGNOSTICA-STAGO: US7208266B2 (2007).
  Google Scholar
• 58 Minoru H, Lion Corp, Atsumi N, Yuichi N, Masako N: WO2007020795A1 (2007).
  Google Scholar
• 59 UNIV JOHN HOPKINS, MERLION PHARMACEUTICAL PTC LTD: WO2008080162A2 (2008).
  Google Scholar
• 60 Ghisalberti C: WO2008065527A3 (2008).
  Google Scholar
• 61 AMGEN INC, Goldenberg MS, Gu JH: CA2563185C (2010).
  Google Scholar
• 62 Naturex SA, Dikansky, Jacques: WO2010021935A1 (2010).
  Google Scholar
• 63 Guthery BE: EP2378872A1 (2011).
  Google Scholar
• 64 Hensley C, Pyo S: US20110257258A1 (2011).
  Google Scholar
• 65 UNILEVER PLC, UNILEVER NV, HINDUSTAN UNILEVER LIMITED: WO2011124573A1 (2011).
  Google Scholar
• 66 BASF SE: WO2011138345A2 (2011).
  Google Scholar
• 67 QUINTILES FINE CHEMICAL CO., LTD: CN101327203B (2011).
  Google Scholar
• 68 J KUNMING INSTITUTE PHARMACEUTICAL CO., LTD: CN102659849A (2012).
  Google Scholar
• 69 GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTITUTE, INC.: EP2400841A1 (2012).
  Google Scholar
• 70 CLEMSON UNIVERSITY RESEARCH FOUNDATION (CURF): US8435553B2 (2013).
  Google Scholar
• 71 NAGAOKA PERFUMERY CO., LTD., NAGAOKA FRAGNANCE CO., LTD.: WO2013005836A1 (2013).
  Google Scholar
• 72 UNILEVER PLC, UNILEVER NV: EP2555828A1 (2013).
  Google Scholar
• 73 CAPITAL MEDICAL UNIVERSITY: CN101768081B (2013).
  Google Scholar
• 74 L'OREAL: WO2010100341A1 (2010).
  Google Scholar
• 75 CAVINKARE PVT. LTD: WO2010106545A1 (2010).
  Google Scholar